Sort
21,281 grants matching “influenza”
Predictive fitness models for influenza vaccine strain selection
$598,951Marta Luksza · Icahn School Of Medicine At Mount Sinai · R01 · FY2023 · AI
Efficient, Scalable Multisource Surveillance Algorithms for BioSense
$598,732Artur Dubrawski · Carnegie-Mellon University · R01 · FY2007 · PH
Efficient, Scalable Multisource Surveillance Algorithms for BioSense
$598,732Artur Dubrawski · Carnegie-Mellon University · R01 · FY2006 · PH
Project 1 - Dixit
$598,513Vishwa Deep Dixit · Yale University · P01 · FY2022 · AG
IMPACT OF RESPIRATORY RNA VIRUSES ON CELLULAR PATHWAYS
$598,357Mount Sinai School Of Medicine Of Nyu · P01 · FY2005 · AI
IMPACT OF RESPIRATORY RNA VIRUSES ON CELLULAR PATHWAYS
$598,357Mount Sinai School Of Medicine Of Nyu · P01 · FY2004 · AI
Defining the four major routes of MHC class II antigen processing and presentation with influenza antigens
$598,313Laurence Crane Eisenlohr · Children'S Hosp Of Philadelphia · R01 · FY2025 · AI
Immune signatures of vaccine responses in children with sickle cell disease
$598,220Inci Burcin Yildirim · Yale University · R01 · FY2025 · AI
Virus Induction of Primary and Memory B- and T-Cell Responses
$598,206Jack R Bennink · National Institute Of Allergy And Infectious Diseases · ZIA · FY2019 · AI
Biology, Evolution and Pathogenesis of Influenza A Virus
$598,206Jack R Bennink · National Institute Of Allergy And Infectious Diseases · ZIA · FY2019 · AI
Control of antiviral-viral B cell responses by IFNy T-bet and Eomes
$597,871Frances E. Lund · University Of Alabama At Birmingham · U19 · FY2018 · AI
Lipid Bilayer Remodeling and Protein Intermediates During Membrane Fusion
$597,847Kelly Keisen Lee · University Of Washington · R01 · FY2022 · AI
Unraveling Human T Follicular Helper Cell Development
$597,818Philip A Mudd · Washington University · R01 · FY2024 · AI
Germline-Specific Immunogens for the Induction of Neutralizing Antibodies to HIV-
$597,816Robert Gerald Whalen · Altravax, Inc. · R01 · FY2012 · AI
Regulation of primary and memory B cell vaccine responses in the elderly
$597,708Daniela Frasca · University Of Miami School Of Medicine · R56 · FY2015 · AG
APC SPECIFIC MTOP INHIBITION POTENTIATES IMMUNE RESPONSE TO IIV IN ELDERLY RECIPIENTS.
$597,598Sam Rothstein · Qrono, Inc · N43 · FY2022 · AI
Development of a novel vaccine platform: Surface Antigen/Adjuvant Vaccine Engineering (SAAVE)
$597,338Michael Stephen Trent · University Of Georgia · R01 · FY2018 · AI
Biocontainment Research Support Service(s) Core-Optional
$597,319Sixto Manuel Leal · University Of Alabama At Birmingham · UC7 · FY2025 · AI
Novel Influenza A Nanovaccines for Broad Cross Protection
$597,227Baozhong Wang · Georgia State University · R01 · FY2016 · AI
Mucosal Protection Against HIV Generated by PIV5 Priming and VLP Boosting
$597,176Paul W. Spearman · Cincinnati Childrens Hosp Med Ctr · R01 · FY2017 · AI
Fungal dysbiosis regulation of post-influenza bacterial pneumonia
$597,122Peter Chen · Cedars-Sinai Medical Center · R01 · FY2022 · HL
Fungal dysbiosis regulation of post-influenza bacterial pneumonia
$597,122Peter Chen · Cedars-Sinai Medical Center · R01 · FY2021 · HL
Fungal dysbiosis regulation of post-influenza bacterial pneumonia
$597,122Peter Chen · Cedars-Sinai Medical Center · R01 · FY2023 · HL
Task Order 2: The Interventional Agent Development Services Program
$596,698Jon Carl Mirsalis · Sri International · N01 · FY2014 · AI
Nanoemulsions as novel adjuvents for influenza virus vaccines
$596,673Yoshihiro Kawaoka · University Of Wisconsin-Madison · U01 · FY2011 · AI